Market Overview:
The global bone cancer treatment market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The market growth is attributed to the increasing incidence of bone cancer, rising awareness about bone cancer treatments, and technological advancements in the field of bone cancer treatments. Based on type, the radiation therapy segment is expected to account for the largest share of the global Bone Cancer Treatment Market in 2018. This segment is projected to grow at a CAGR of 7.8% from 2018 to 2030 due to its high efficacy and low side-effects as compared to other treatment modalities.
Product Definition:
Bone cancer is a type of cancer that starts in the bones. Treatment options vary depending on the type and stage of bone cancer. Surgery, radiation therapy, and chemotherapy are all possible treatments for bone cancer.
Radiation Therapy:
Radiation therapy is a cancer treatment that uses high energy waves to fight cancer. The radiation oncologists or radiotherapists use external beam radiation therapy, intraoperative radiotherapy, and radioisotope therapy. External Beam Radiation Therapy (EBRT) includes CyberKnife, Gamma Knife, and tomotherapy.
Chemotherapy:
Chemotherapy is the use of drugs or chemical agents to treat cancer. The most common types of cancers that are treated with chemotherapy include breast cancer, lung cancer, prostate cancer, and bone & brain tumors. Chemotherapy may be used in combination with radiation therapy or surgery (inoperative treatment). Some chemotherapy drugs may also have side effects which can be managed by monitoring certain blood parameters.
The global Bone Cancer Treatment market size was valued at USD 1.8 billion in 2016.
Application Insights:
The diffuse bone cancer segment dominated the market in 2017 and is expected to witness lucrative growth over the forecast period owing to increasing incidence rates of this disease. The other applications include osteosarcoma, Ewing¢â‚¬â„¢s tumor, and primary bone metastasis.
Nodular bone cancer is anticipated to be the fastest-growing application segment during the forecast period due to rising incidence rates of this disease. Owing to advancements in treatment methods such as intensity-modulated radiation therapy (IMRT), stereotactic body radiation therapy (SBRT), and image-guided surgery that help reduce local recurrences and complications associated with nodular osteosarcoma, thereby driving its adoption rate among other applications across various geographies.
Regional Analysis:
North America dominated the global bone cancer treatment market in 2017. This can be attributed to the presence of key players, high disposable income, and availability of technologically advanced products. Moreover, increasing government funding for R&D activities is also expected to drive growth during the forecast period. For instance, as per a press release by U.
Asia Pacific region is anticipated to witness lucrative growth over the forecast period owing to rising healthcare expenditure by governments.
Growth Factors:
- Increasing incidence of bone cancer
- Rising awareness about bone cancer treatment options
- Growing demand for minimally invasive procedures for bone cancer treatment
- Technological advancements in bone cancer treatment therapies
- increasing healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
Bone Cancer Treatment Market Research Report
By Type
Radiation Therapy, Chemotherapy, Surgical Treatments, Cryosurgery, Drugs, Bone Cancer Treatmen
By Application
Diffuse Bone Cancer, Nodular Bone Cancer, Necrotizing Bone Cancer, Other
By Companies
Bayer AG, Amgen, Novartis AG, Pfizer, AstraZeneca, Dr. Reddy's Laboratories (DRL), Actavis, Bristol-Myers Squibb, Celgene Corporation, Eli Lilly, Roche, GlaxoSmithKline, Sanofi, Amneal Pharmaceuticals LLC, Baxter International, BoehringerIngelheim, Fresenius Kabi, Jubilant Cadista Pharmaceuticals, Mylan Pharmaceuticals, Perrigo Company, Roxane Laboratories, Sandoz, Henlius Biotech, Teva Pharmaceuticals USA, West-Ward Pharmaceuticals, Zydus Pharmaceuticals (Cadila Healthcare), Bone Cancer Treatmen
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
250
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Bone Cancer Treatment Market Report Segments:
The global Bone Cancer Treatment market is segmented on the basis of:
Types
Radiation Therapy, Chemotherapy, Surgical Treatments, Cryosurgery, Drugs, Bone Cancer Treatmen
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Diffuse Bone Cancer, Nodular Bone Cancer, Necrotizing Bone Cancer, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bayer AG
- Amgen
- Novartis AG
- Pfizer
- AstraZeneca
- Dr. Reddy's Laboratories (DRL)
- Actavis
- Bristol-Myers Squibb
- Celgene Corporation
- Eli Lilly
- Roche
- GlaxoSmithKline
- Sanofi
- Amneal Pharmaceuticals LLC
- Baxter International
- BoehringerIngelheim
- Fresenius Kabi
- Jubilant Cadista Pharmaceuticals
- Mylan Pharmaceuticals
- Perrigo Company
- Roxane Laboratories
- Sandoz
- Henlius Biotech
- Teva Pharmaceuticals USA
- West-Ward Pharmaceuticals
- Zydus Pharmaceuticals (Cadila Healthcare)
- Bone Cancer Treatmen
Highlights of The Bone Cancer Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Radiation Therapy
- Chemotherapy
- Surgical Treatments
- Cryosurgery
- Drugs
- Bone Cancer Treatmen
- By Application:
- Diffuse Bone Cancer
- Nodular Bone Cancer
- Necrotizing Bone Cancer
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Bone Cancer Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Bone cancer treatment typically includes surgery to remove the tumor, chemotherapy and radiation therapy.
Some of the key players operating in the bone cancer treatment market are Bayer AG, Amgen, Novartis AG, Pfizer, AstraZeneca, Dr. Reddy's Laboratories (DRL), Actavis, Bristol-Myers Squibb, Celgene Corporation, Eli Lilly, Roche, GlaxoSmithKline, Sanofi, Amneal Pharmaceuticals LLC, Baxter International, BoehringerIngelheim, Fresenius Kabi, Jubilant Cadista Pharmaceuticals, Mylan Pharmaceuticals, Perrigo Company, Roxane Laboratories, Sandoz, Henlius Biotech, Teva Pharmaceuticals USA, West-Ward Pharmaceuticals, Zydus Pharmaceuticals (Cadila Healthcare), Bone Cancer Treatmen.
The bone cancer treatment market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Bone Cancer Treatment Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Bone Cancer Treatment Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Bone Cancer Treatment Market - Supply Chain
4.5. Global Bone Cancer Treatment Market Forecast
4.5.1. Bone Cancer Treatment Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Bone Cancer Treatment Market Size (000 Units) and Y-o-Y Growth
4.5.3. Bone Cancer Treatment Market Absolute $ Opportunity
5. Global Bone Cancer Treatment Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Bone Cancer Treatment Market Size and Volume Forecast by Type
5.3.1. Radiation Therapy
5.3.2. Chemotherapy
5.3.3. Surgical Treatments
5.3.4. Cryosurgery
5.3.5. Drugs
5.3.6. Bone Cancer Treatmen
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Bone Cancer Treatment Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Bone Cancer Treatment Market Size and Volume Forecast by Application
6.3.1. Diffuse Bone Cancer
6.3.2. Nodular Bone Cancer
6.3.3. Necrotizing Bone Cancer
6.3.4. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Bone Cancer Treatment Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Bone Cancer Treatment Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Bone Cancer Treatment Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Bone Cancer Treatment Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Bone Cancer Treatment Demand Share Forecast, 2019-2026
9. North America Bone Cancer Treatment Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Bone Cancer Treatment Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Bone Cancer Treatment Market Size and Volume Forecast by Application
9.4.1. Diffuse Bone Cancer
9.4.2. Nodular Bone Cancer
9.4.3. Necrotizing Bone Cancer
9.4.4. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Bone Cancer Treatment Market Size and Volume Forecast by Type
9.7.1. Radiation Therapy
9.7.2. Chemotherapy
9.7.3. Surgical Treatments
9.7.4. Cryosurgery
9.7.5. Drugs
9.7.6. Bone Cancer Treatmen
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Bone Cancer Treatment Demand Share Forecast, 2019-2026
10. Latin America Bone Cancer Treatment Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Bone Cancer Treatment Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Bone Cancer Treatment Market Size and Volume Forecast by Application
10.4.1. Diffuse Bone Cancer
10.4.2. Nodular Bone Cancer
10.4.3. Necrotizing Bone Cancer
10.4.4. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Bone Cancer Treatment Market Size and Volume Forecast by Type
10.7.1. Radiation Therapy
10.7.2. Chemotherapy
10.7.3. Surgical Treatments
10.7.4. Cryosurgery
10.7.5. Drugs
10.7.6. Bone Cancer Treatmen
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Bone Cancer Treatment Demand Share Forecast, 2019-2026
11. Europe Bone Cancer Treatment Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Bone Cancer Treatment Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Bone Cancer Treatment Market Size and Volume Forecast by Application
11.4.1. Diffuse Bone Cancer
11.4.2. Nodular Bone Cancer
11.4.3. Necrotizing Bone Cancer
11.4.4. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Bone Cancer Treatment Market Size and Volume Forecast by Type
11.7.1. Radiation Therapy
11.7.2. Chemotherapy
11.7.3. Surgical Treatments
11.7.4. Cryosurgery
11.7.5. Drugs
11.7.6 Bone Cancer Treatmen
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Bone Cancer Treatment Demand Share, 2019-2026
12. Asia Pacific Bone Cancer Treatment Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Bone Cancer Treatment Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Bone Cancer Treatment Market Size and Volume Forecast by Application
12.4.1. Diffuse Bone Cancer
12.4.2. Nodular Bone Cancer
12.4.3. Necrotizing Bone Cancer
12.4.4. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Bone Cancer Treatment Market Size and Volume Forecast by Type
12.7.1. Radiation Therapy
12.7.2. Chemotherapy
12.7.3. Surgical Treatments
12.7.4. Cryosurgery
12.7.5. Drugs
12.7.6. Bone Cancer Treatmen
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Bone Cancer Treatment Demand Share, 2019-2026
13. Middle East & Africa Bone Cancer Treatment Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Bone Cancer Treatment Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Bone Cancer Treatment Market Size and Volume Forecast by Application
13.4.1. Diffuse Bone Cancer
13.4.2. Nodular Bone Cancer
13.4.3. Necrotizing Bone Cancer
13.4.4. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Bone Cancer Treatment Market Size and Volume Forecast by Type
13.7.1. Radiation Therapy
13.7.2. Chemotherapy
13.7.3. Surgical Treatments
13.7.4. Cryosurgery
13.7.5. Drugs
13.7.6. Bone Cancer Treatmen
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Bone Cancer Treatment Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Bone Cancer Treatment Market: Market Share Analysis
14.2. Bone Cancer Treatment Distributors and Customers
14.3. Bone Cancer Treatment Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Bayer AG
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Amgen
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Novartis AG
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Pfizer
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. AstraZeneca
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Dr. Reddy's Laboratories (DRL)
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Actavis
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Bristol-Myers Squibb
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Celgene Corporation
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Eli Lilly
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Roche
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. GlaxoSmithKline
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Sanofi
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Amneal Pharmaceuticals LLC
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Baxter International
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. BoehringerIngelheim
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. Fresenius Kabi
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. Jubilant Cadista Pharmaceuticals
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. Mylan Pharmaceuticals
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. Perrigo Company
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
